Edap TMS SA $FOCL
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Market
- Sector
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- 69120 Vaulx En Velin, France
- Fiscal year end
- December 31
- Shares outstanding
- 37,527,950 [10-Q 2026-08-14]
What the company doesAI summary of filing
EDAP TMS SA is a revenue-generating medical technology company that develops, manufactures, and sells non-invasive therapeutic ultrasound and energy-based medical devices. The company's primary product is the Focal One Robotic HIFU System, which uses High Intensity Focused Ultrasound technology for the ablation of prostate tissue and is approved for sale in the United States and Europe. EDAP generates revenue from the sale of capital equipment as well as recurring revenue from consumables and maintenance services. The company is also conducting clinical development activities to expand Focal One applications to benign prostatic hyperplasia and endometriosis treatment. [10-K 2026-03-25]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $24.80M | −$23.57M | −$6.66M | $21.54M | [10-Q 2026-08-14] |
| FY ended Dec 2025 | $70.53M | −$29.25M | −$16.41M | $20.45M | [10-K 2026-03-25] |
| FY ended Dec 2024 | $69.39M | −$20.58M | −$14.70M | $31.00M | [10-K 2026-03-25] |
- Quarterly cash burn
- −$3.33M
- Cash runway Estimate
- ~19.4 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2023-12-31 | 37,103,779 | [20-F 2024-03-28] |
| 2024-12-31 | 37,392,086 | [20-F 2025-03-27] |
| 2026-03-25 | 37,481,986 | [10-K 2026-03-25] |
| 2026-05-06 | 37,481,986 | [10-Q 2026-05-07] |
| 2026-08-14 | 37,527,950 | [10-Q 2026-08-14] |
- Shelf registration
- S-3 filed 2026-03-25; declared effective 2026-03-31 [S-3 2026-03-25]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Horn David R. | buy | 10,000 | $4.75 | [4 2026-08-17] |
| 2026-08-14 | Schulz Fran | buy | 10,000 | $4.75 | [4 2026-08-17] |
| 2026-08-14 | Levine Joshua | buy | 10,000 | $4.75 | [4 2026-08-17] |
| 2026-08-14 | Mobeck Kenneth S. | buy | 5,000 | $4.75 | [4 2026-08-17] |
| 2026-08-14 | Willsey Lance | buy | 50,000 | $4.75 | [4 2026-08-17] |
| 2026-08-14 | Rhodes Ryan | buy | 21,000 | $4.75 | [4 2026-08-17] |
| 2026-08-14 | Shah Sanket | buy | 5,000 | $4.75 | [4 2026-08-17] |
| 2026-08-14 | Annen Steven | buy | 5,000 | $4.75 | [4 2026-08-17] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-19 | 8-K | Other events |
| 2026-08-14 | 10-Q | Quarterly report |
| 2026-08-14 | 8-K | Material agreement entered |
| 2026-08-13 | 8-K | Results of operations |
| 2026-08-12 | 424B5 | Prospectus or prospectus supplement |
| 2026-08-12 | 424B5 | Prospectus or prospectus supplement |
| 2026-08-11 | 8-K | Results of operations; Regulation FD disclosure; Other events |
| 2026-06-26 | 8-K | Charter, bylaws or fiscal year change; Shareholder vote results |
| 2026-06-01 | 8-K | Regulation FD disclosure |
| 2026-05-29 | 8-K | Other events |
| 2026-05-14 | DEF 14A | Proxy statement |
| 2026-05-07 | 10-Q | Quarterly report |
Alerts for $FOCL
Email me when Edap TMS SA files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.